CytoNiche Overview

  • Founded
  • 2018
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $47.2M
Latest Deal Amount
  • Investors
  • 16

CytoNiche General Information

Description

Developer of 3D micro-structure engineering technology used for stem cell research. The company specializes in the research of 3D cell tissue engineering for the development of high-quality stem cell cultures, injectable 3D micro-tissue treatment and 3D drug screening microcarrier used for extensive drug screening operations, providing reliable 3D micro-tissue products and services for research institutes, clinical institutions, stem cell companies and drug research enterprises.

Contact Information

Website
www.cytoniche.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Room 208, Building 1, Zone B
  • Yiyuan Wenchuang Base, Haidian District
  • Beijing
  • China
+86 010 0000 0000

CytoNiche Timeline

2019202020212022
Date FoundedFinancing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CytoNiche Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 03-Mar-2022 $47.2M 000.00 Completed Generating Revenue
3. Early Stage VC (Series A1) 28-Apr-2021 Completed Generating Revenue
2. Early Stage VC (Series A) 03-Sep-2020 Completed Generating Revenue
1. Seed Round 01-Mar-2019 Completed Startup
To view CytoNiche’s complete valuation and funding history, request access »

CytoNiche Patents

  • 1

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

CytoNiche Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210277380-A1 Aggregate of cell carrier particles and method for preparing same Pending 28-Jan-2019 0000000000

CytoNiche Executive Team (1)

Name Title Board Seat Contact Info
Wei Liu Ph.D Co-Founder and Chief Executive Officer
To view CytoNiche’s complete executive team members history, request access »

CytoNiche Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CICC Capital PE/Buyout Minority 000 0000 000000 0
Gaorong Capital Venture Capital Minority 000 0000 000000 0
Hongtai Capital Holdings Venture Capital Minority 000 0000 000000 0
Sinopharm Capital Venture Capital Minority 000 0000 000000 0
Sinovac Corporation Minority 000 0000 000000 0
You’re viewing 5 of 16 investors. Get the full list »

Ready to get started?

Request a free trial